Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine

Decitabine improves overall survival (OS) and reduces risk of progression to acute myeloid leukemia (AML) in myelodysplastic syndromes (MDS). In this retrospective analysis of data from 2 decitabine studies (n = 162), hemoglobin level > 10 g/dL, platelet count > 50 × 10(3)/μL, and lack of chro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jabbour, Elias, Garcia-Manero, Guillermo, Ravandi, Farhad, Faderl, Stefan, O'Brien, Susan, Fullmer, Amber, Cortes, Jorge E., Wierda, William, Kantarjian, Hagop
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098775/
https://ncbi.nlm.nih.gov/pubmed/23260600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2012.11.001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller